TMCnet News
US Lumpectomy Market 2018-2022 - Obesity and Hormone Replacement Therapies are the Key Factors for New Breast Cancer Cases - ResearchAndMarkets.comThe "Lumpectomy Market in the US 2018-2022" report has been added to ResearchAndMarkets.com's offering. US lumpectomy market to grow at a CAGR of 4.61% during the period 2018-2022. The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. One trend in the market is presence of venture capitalists. Most of the companies that are focusing on developing lumpectomy products are US-based companies. They are focused on developing novel technologies and to bring those products into the market for which they need funding for R&D and to conduct clinical trials. Hence, both small and large companies, which manufacture lumpectomy products, need funding sources or investors.
Further, the report states that one challenge in the market is the high cost of lumpectomy procedures. Key Vendors
Key Topics Covered: Part 01: Executive Summary Part 02: Scope of the Report Part 03: Research Methodology Part 04: Market Landscape Part 05: Market Sizing Part 06: Five Forces Analysis Part 07: Market Segmentation by Product Part 08: Customer Landscape Part 09: Market Segmentation by End-Users Part 10: Decision Framework Part 11: Drivers and Challenges Part 12: Market Trends Part 13: Vendor Landscape Part 14: Vendor Analysis For more information about this report visit https://www.researchandmarkets.com/research/jmv28x/us_lumpectomy?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20180214006188/en/ |
